N/A
Completed N=30
Fathering In Recovery
Parenting · Opioid Use Disorder · Father-Child Relations · Fathers
Source: ClinicalTrials.gov NCT04611542 ↗
Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcomePrimary: Parenting Practices Interview — 2.84; 3.83 score on a scale — p=<0.001
Summary
The majority of men experiencing opioid use disorder and receiving treatment are fathers. Substance use, transitions between in-patient and out-patient treatment, and reunification as a family, all create considerable strain and are predictive of a host of negative long-term outcomes including increased rates of relapse for fathers and elevated risk for behavioral, emotional, and substance use problems in their children. Evidence-based parenting interventions for fathers are lacking in general, yet are exceedingly rare for fathers participating in opioid use disorder treatment, even though the extant research literature suggests the integration of services is not only timely but may help engage and retain fathers in treatment and produce protective factors for children. The goal of this project is to develop and evaluate a prototype of a usable innovative web-based program that integrates existing evidence-based parenting programs, yet tailored specifically to fathers with opioid use disorder and designed for the opioid treatment context in order to promote the implementation and dissemination of father specific empirically-supported treatment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Parenting Practices Interview |
2.84; 3.83 | <0.001 sig |
| PRIMARY Parenting Efficacy |
6.27; 7.39 | <.001 sig |
| PRIMARY Program Knowledge |
2.54; 8.86 | <0.001 sig |
Eligibility Criteria
Inclusion:
- Father with at least part time custody of at least one child between the ages 3-12
- In recovery from OUD
- English-speaking
- Abstinent from substances other than marijuana and alcohol for no more than 1 year
- Has access to technology allowing for watching internet-based videos such as a smart phone or similar device. Participants will be screened for eligibility criteria by Influents Innovations staff.
Data sourced from ClinicalTrials.gov (NCT04611542). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.